Again, the point of the hearing is how do we maintain quality, how do we encourage the pharmaceutical sector to innovate and take some risks, but how do we get a handle on the enormous cost of providing drugs to Americans.
Mark Udall: “Again, the point of the hearing is how do we maintain quality, how do we encourage the pharmaceutical sector to innovate…”
On the recordJuly 20, 2011
Source
congress.govEditor's note · Context
Udall highlights the need to balance drug quality, innovation, and costs.
Share
More from Mark Udall
Sep 15, 2015
The 1872 mining law continues to allow mining corporations to take hard rock minerals from public lands without paying any royalties.
Jul 15, 2014
General Shelton, with the Air Force technical oversight by DOD and Federally Funded Research and Development Centers, did contractor personnel go through a process of demonstrating the ability to build some of the most complex components…
Oct 6, 2015
Senators Jerry Moran and Mark Udall recently sent a letter to the Office of Management and Budget outlining areas where improvements can be made.
Jan 28, 2015
We're talking about free trade also, right? I mean, this is the intersection of two sets of policies.





